Projects per year
Fingerprint
Dive into the research topics where David H Munn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Chemo-radio immunotherapy for pediatric brain tumors
Project: Research project
-
IDO-expressing plasmacytoid dendritic cells and tumors
Munn, D. H., MUNN, D., MUNN, D. H., MUNN, D. H. & MUNN, D. H.
1/14/05 → 6/30/15
Project: Research project
-
IDO-expressing immunoregulatory dendritic cells
Munn, D. H., MUNN, D. H., MUNN, D. H., MUNN, D. H. & MUNN, D. H.
7/1/03 → 5/31/19
Project: Research project
-
Role of IDO in Malignancy
Munn, D. H., MUNN, D. H., MUNN, D. H. & MUNN, D. H.
7/1/02 → 6/30/17
Project: Research project
Research output
-
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Zakharia, Y., McWilliams, R. R., Rixe, O., Drabick, J., Shaheen, M. F., Grossmann, K. F., Kolhe, R., Pacholczyk, R., Sadek, R., Tennant, L. L., Smith, C. M., Kennedy, E. P., Link, C. J., Vahanian, N. N., Yu, J., Shen, S. S., Brincks, E. L., Rossi, G. R., Munn, D. & Milhem, M., Jun 11 2021, In: Journal for ImmunoTherapy of Cancer. 9, 6, e002057.Research output: Contribution to journal › Article › peer-review
Open Access -
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
Thangavelu, G., Wang, C., Loschi, M., Saha, A., Osborn, M. J., Furlan, S. N., Aoyama, K., McDonald-Hyman, C., Aguilar, E. G., Janesick, A. S., Chandraratna, R. A., Refaeli, Y., Panoskaltsis-Mortari, A., MacDonald, K. P., Hill, G. R., Zeiser, R., Maillard, I., Serody, J. S., Murphy, W. J., Munn, D. H. & 7 others, , Feb 25 2021, In: Blood. 137, 8, p. 1090-1103 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma
Ladomersky, E., Zhai, L., Lauing, K. L., Bell, A., Xu, J., Kocherginsky, M., Zhang, B., Wu, J. D., Podojil, J. R., Platanias, L. C., Mochizuki, A. Y., Prins, R. M., Kumthekar, P., Raizer, J. J., Dixit, K., Lukas, R. V., Horbinski, C., Wei, M., Zhou, C., Pawelec, G. & 5 others, , Oct 1 2020, In: Clinical Cancer Research. 26, 19, p. 5232-5245 14 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
Yu, M., Guo, G., Huang, L., Deng, L., Chang, C. S., Achyut, B. R., Canning, M., Xu, N., Arbab, A. S., Bollag, R. J., Rodriguez, P. C., Mellor, A. L., Shi, H., Munn, D. H. & Cui, Y., Dec 1 2020, In: Nature communications. 11, 1, 515.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations -
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells
Artham, S., Verma, A., Alwhaibi, A., Adil, M. S., Manicassamy, S., Munn, D. H. & Somanath, P. R., Apr 2020, In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 318, 4, p. L750-L761Research output: Contribution to journal › Article › peer-review
6 Scopus citations